What can be done to prevent graft versus host disease?

This publication has 37 references indexed in Scilit:

• Cytokine dysregulation as a mechanism of graft versus host disease
  Published by Elsevier ,2004
• T CELL SUBSETS INVOLVED IN LETHAL GRAFT-VERSUS-HOST DISEASE DIRECTED TO IMMUNODOMINANT MINOR HISTOCOMPATIBILITY ANTIGENS
  Transplantation, 1994
• THE ROLE OF HOST T CELL SUBSETS IN BONE MARROW REJECTION DIRECTED TO ISOLATED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I VERSUS CLASS II DIFFERENCES OF bm1 and bm12 MUTANT MICE1,2
  Transplantation, 1994
• Novel approaches to the control of graft versus host disease
  Current Opinion in Immunology, 1993
• Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+ CD4- and not by CD8- CD4+ thymocytes
  Blood, 1992
• T CELL SUBSETS REQUIRED FOR IN VIVO AND IN VITRO RESPONSES TO SINGLE AND MULTIPLE MINOR HISTOCOMPATIBILITY ANTIGENS
  Transplantation, 1992
• A DECREASE IN GRAFT-VS.-HOST DISEASE WITHOUT LOSS OF GRAFT-VS.-LEUKEMIA REACTIVITY AFTER MHC-MATCHED BONE MARROW TRANSPLANTATION BY SELECTIVE DEPLETION OF DONOR NK CELLS IN VIVO
  Transplantation, 1992
• Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts
  Blood, 1989
• Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
  Nature, 1986
• The Depletion of T Cell Subsets in Vitro and in Vivo
  Transplantation, 1986